Researchers identify a possible therapeutic target for Kennedy´s disease and prostate cancer

by Institute for Research in Biomedicine (IRB Barcelona)Interaction of the androgen receptor and chaperone Hsp70 (in red) inside the cell. Blue indicates cell nuclei.Xavier Salvatella, IRB Barcel

Updated on: June 06,2024 5

Researchers identify a possible therapeutic target for Kennedy´s disease and prostate cancer

by Institute for Research in Biomedicine (IRB Barcelona)Interaction of the androgen receptor and chaperone Hsp70 (in red) inside the cell. Blue indicates cell nuclei.Xavier Salvatella, IRB Barcel

Updated on:June 06,2024 5

Colorectal cancer: New approach for better efficacy of immunotherapies

byMedical University of ViennaSingle-cell RNA- and TCR sequencing reveal favored Vδ1+ usage with expanded CDR3 identity patterns in γδ T cells of MSS CRC. Credit:Nature Communications&nbsp

Updated on: September 07,2024 0

Colorectal cancer: New approach for better efficacy of immunotherapies

byMedical University of ViennaSingle-cell RNA- and TCR sequencing reveal favored Vδ1+ usage with expanded CDR3 identity patterns in γδ T cells of MSS CRC. Credit:Nature Communications&nbsp

Updated on:September 07,2024 0

Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

by University of Texas M. D. Anderson Cancer CenterA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/Wikimedia/CC

Updated on: May 17,2024 3

Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

by University of Texas M. D. Anderson Cancer CenterA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/Wikimedia/CC

Updated on:May 17,2024 3

Novel genomics tool enables more accurate identification of rare mutations in cancer cells

by New York Genome CenterExample of colored de Bruijn graph rendered to represent genomic data for a short region of 400 base pairs using the Lancet genomics tool developed by New York Genome Center s

Updated on: March 01,2024 10

Novel genomics tool enables more accurate identification of rare mutations in cancer cells

by New York Genome CenterExample of colored de Bruijn graph rendered to represent genomic data for a short region of 400 base pairs using the Lancet genomics tool developed by New York Genome Center s

Updated on:March 01,2024 10

How a new breast cancer biomarker could help patients identify best treatment options

by Dong-Xu Liu,The ConversationCredit: AI-generated imageAccording to the latestGLOBOCAN cancer database, New Zealand's breast cancer incidence rate is among the highest in the world.

Updated on: May 17,2024 8

How a new breast cancer biomarker could help patients identify best treatment options

by Dong-Xu Liu,The ConversationCredit: AI-generated imageAccording to the latestGLOBOCAN cancer database, New Zealand's breast cancer incidence rate is among the highest in the world.

Updated on:May 17,2024 8

New bioinformatics tool to identify chromosomal alterations in tumor cells

by University of BarcelonaRepresentative output image generated by QATS in which two toroidal nuclei (in magenta) and four micronuclei (in green) were identified. Credit:Bioinformatics&nbsp

Updated on: March 30,2024 0

New bioinformatics tool to identify chromosomal alterations in tumor cells

by University of BarcelonaRepresentative output image generated by QATS in which two toroidal nuclei (in magenta) and four micronuclei (in green) were identified. Credit:Bioinformatics&nbsp

Updated on:March 30,2024 0

Researchers identify potential new combination treatment for pancreatic cancer

by Denise Heady,University of California, Los AngelesPancreatic cancer (the cancer cells are seen here) is the third leading cause of cancer-related deaths in the United States. Credit: Universi

Updated on: March 01,2024 17

Researchers identify potential new combination treatment for pancreatic cancer

by Denise Heady,University of California, Los AngelesPancreatic cancer (the cancer cells are seen here) is the third leading cause of cancer-related deaths in the United States. Credit: Universi

Updated on:March 01,2024 17

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according

Updated on: March 30,2024 0

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according

Updated on:March 30,2024 0

When should NHS contact patients over faulty genes?

by University of ExeterCredit: CC0 Public DomainThe NHS and health services worldwide need to develop policies on when patients should be "re-contacted" about faulty genes, as the curre

Updated on: May 11,2024 7

When should NHS contact patients over faulty genes?

by University of ExeterCredit: CC0 Public DomainThe NHS and health services worldwide need to develop policies on when patients should be "re-contacted" about faulty genes, as the curre

Updated on:May 11,2024 7

HPV vaccine eliminates advanced skin cancer in 97-year-old

(HealthDay)—The 9-valent human papillomavirus (HPV) vaccine could be a therapeutic option for patients with cutaneous squamous cell carcinoma when surgical management is not an option, according to a

Updated on: March 12,2024 11

HPV vaccine eliminates advanced skin cancer in 97-year-old

(HealthDay)—The 9-valent human papillomavirus (HPV) vaccine could be a therapeutic option for patients with cutaneous squamous cell carcinoma when surgical management is not an option, according to a

Updated on:March 12,2024 11

Drug hobbles deadly liver cancer by stifling protein production

by University of California, San FranciscoCredit: CC0 Public DomainIn laboratory experiments, UC San Francisco researchers successfully beat back the growth of aggressive liver cancers using a su

Updated on: May 25,2024 5

Drug hobbles deadly liver cancer by stifling protein production

by University of California, San FranciscoCredit: CC0 Public DomainIn laboratory experiments, UC San Francisco researchers successfully beat back the growth of aggressive liver cancers using a su

Updated on:May 25,2024 5

Radiation therapy for patients with breast cancer explained

by Mayo Clinic News NetworkCredit: Unsplash/CC0 Public DomainRadiation therapy is a common component of breast cancer treatment for patients. The high-powered beams of intense energy kill cancer cells

Updated on: November 08,2024 0

Radiation therapy for patients with breast cancer explained

by Mayo Clinic News NetworkCredit: Unsplash/CC0 Public DomainRadiation therapy is a common component of breast cancer treatment for patients. The high-powered beams of intense energy kill cancer cells

Updated on:November 08,2024 0